04/12/2022 8:57 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/13/2021 8:06 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2021 2:47 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/14/2021 2:51 PM | CNBX Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/06/2021 11:23 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/17/2021 11:16 PM | CNBX Pharmaceuticals (Filer)
| Form EFFECT
| |
05/10/2021 9:40 AM | CNBX Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
04/28/2021 6:47 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/14/2021 11:42 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
03/11/2021 11:15 PM | CNBX Pharmaceuticals (Filer)
| Form EFFECT
| |
|
02/23/2021 2:27 PM | CNBX Pharmaceuticals (Filer)
| Form S-1/A
| |
01/27/2021 9:08 AM | CNBX Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
12/21/2020 7:54 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/16/2020 9:35 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2020 10:21 AM | CNBX Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
09/02/2020 2:34 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/14/2020 11:24 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/16/2020 7:03 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2020 7:01 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/14/2020 3:03 PM | CNBX Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/29/2019 8:04 AM | CNBX Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
11/07/2019 4:13 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/11/2019 3:10 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/07/2019 9:00 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/03/2019 12:01 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/23/2019 12:45 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/15/2019 2:29 PM | CNBX Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/25/2019 11:10 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/15/2019 11:37 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
03/27/2019 3:05 PM | CNBX Pharmaceuticals (Filed by) Wize Pharma, Inc. (Subject)
| Form SC 13G
| |
02/13/2019 8:25 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/04/2019 12:21 PM | CNBX Pharmaceuticals (Reporting) SEEDO CORP. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/17/2019 9:37 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
01/14/2019 4:00 PM | CNBX Pharmaceuticals (Filer)
| Form NT 10-Q
| |
11/29/2018 1:36 PM | CNBX Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
09/26/2018 7:04 AM | CNBX Pharmaceuticals (Filer)
| Form 424B5
| |
09/12/2018 8:09 AM | CNBX Pharmaceuticals (Filer)
| Form 424B2
| |
08/21/2018 12:36 PM | CNBX Pharmaceuticals (Filer)
| Form 424B2
| |
08/14/2018 11:59 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/16/2018 7:06 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/01/2018 3:31 PM | CNBX Pharmaceuticals (Filer)
| Form 424B2
| |
05/02/2018 8:38 AM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2018 11:07 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
01/30/2018 2:04 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/16/2018 7:02 AM | CNBX Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
12/19/2017 2:55 PM | CNBX Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/08/2017 8:20 AM | CNBX Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
11/29/2017 2:37 PM | CNBX Pharmaceuticals (Filer)
| Form NT 10-K
| |